⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Skin reticulologistiocytoma✘Ovarian androblastoma
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(0)100%(0)
Thyroid hormones —94%(4)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 97%—
Register, to see more distinctive signs of diseases and studies —96%
rashes over the upper lip 39% —
increase of triiodothyronine free — 94%
rashes itchy 32% —
increased triiodothyronine — 93%
fibrosarcoma 31% —
ovarian androblastoma — 84%
rash on the tongue 30% —
increased — 75%
xanthomas 28% —
increased hairiness — 53%
rash over the lip 28% —
clitoris — 47%
needs understanding 27% —
uterine appendages are increase — 45%
itchy skin 27% —
hirsutism — 45%
onychodystrophy 27% —
hair loss on the crown — 44%
rashes in the folds of the skin 26% —
amenorrhea — 41%
papules 26% —
vaginal discharge — 39%
joint diseases 25% —
monthly gas scanty — 39%
myeloma 25% —
ovarian tumors — 39%
melanoma 25% —
bloody discharge from the vagina — 37%
skin lymphoma 25% —
baldness in the frontal region — 37%
primary-multiple tumors 24% —
stopped menstruation — 36%
rash in the mouth 24% —
receding hairline — 34%
fibroma 23% —
acne — 34%
sarcoidosis 23% —
virile syndrome — 34%
malignant lymphoma 22% —
ovarian apoplexy — 34%
uterine tumor 22% —
pimples on the face — 34%
breast tumor 22% —
acne face — 33%
improper nutrition 22% —
rough voice — 33%
skin atrophy 22% —
clitoromegaly — 31%
polyarthritis 22% —
menstruation disorder — 31%
lipoidosis 22% —
hypertrophy of the uterine body — 31%
head tumor 21% —
rashes on the face — 30%
small rash 21% —
involution of the mammary glands — 30%
inflammation 21% —
pimples on the body — 30%
skin cancer 21% —
excess testesterone — 28%
lymphoma 21% —
monthly short — 28%
lymph node damage 20% —
vaginal discharge in girls — 27%
impaired uterine function 20% —
premature menstruation — 27%
joint deformation 20% —
appendages of pain — 27%
bacteremia 19% —
additional mammary gland — 27%
tuberculosis 19% —
rupture of the uterus — 27%
arthritis 19% —
long monthly cycle — 26%
bronchial lesion 19% —
rapid weight loss 18% 44%
better to be alone 18% —
loss body weight 18% 44%
sepsis 18% —
altered voice — 26%
stress 17% —
testesterone deficiency — 26%
feeling of bruising 17% —
rashes on the genitals — 25%
acute condition 17% —
premature sexual development — 25%
allergy 17% —
removal of the uterine body — 25%
swelling 16% —
appendages of the uterus 20% 45%
diseases of the gastrointestinal tract 16% —
postmenopause — 24%
blood diseases 16% —
change in appetite — 24%
angiopathy 16% —
baldness — 24%
skin problems 35% 22%
to increase the mammary glands — 24%
does not tolerate pain 26% 19%
solid tumors — 23%
fat deposits — 23%
voice disorders — 22%
menopause — 22%
hair loss — 22%
rash on the body — 22%
apoplexy — 22%
indecision — 22%
lowered — 21%
weight change — 20%
myocardial infarction — 20%
radiation therapy — 19%
muscle pain — 19%
no appetite — 19%
general weakness — 19%
radiation damage — 18%
aching — 18%
exhaustion — 18%
high temperature — 17%
feeling of heat — 17%
necrosis — 17%
consequences of surgery — 17%
there are no complaints — 16%
history of surgery 21% 33%
cancer 17% 24%
cysts 18% 18%
genital neoplasms 21% 21%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.